Article Information
History
- August 15, 2021.
Article Versions
- Version 1 (August 12, 2021 - 06:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sebastian Havervall, MD#,1,
- Ulrika Marking, MD#,1,
- Max Gordon, MD, PhD1,
- Henry Ng, MMSc1,2,
- Nina Greilert-Norin, RN1,
- Sarah Lindbo, PhD3,
- Kim Blom, PhD4,
- Peter Nilsson, PhD3,
- Mia Phillipson, PhD2,
- Jonas Klingström, PhD4,5,
- Sara Mangsbo, PhD6,
- Mikael Åberg, PhD7,
- Sophia Hober, PhD#,3 and
- Charlotte Thålin, MD, PhD#,1,*
- 1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
- 2Department of Medical Cell Biology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- 3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
- 4Public Health Agency of Sweden, Solna, Sweden
- 5Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
- 6Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- 7Department of Medical Sciences, Clinical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- ↵*Corresponding author: Charlotte Thålin, MD, PhD, Karolinska institutet, Danderyd hospital, 18288 Stockholm, Sweden, Phone: +46 812355000, Mail: charlotte.thalin{at}sll.se
↵# These authors contributed equally
Posted August 15, 2021.
